
{"id":47870,"date":"2025-04-24T08:44:48","date_gmt":"2025-04-24T07:44:48","guid":{"rendered":"https:\/\/www.btitrainingcenter.com\/platelet-rich-plasma-activation-are-there-differential-effects-in-reproductive-medicine\/"},"modified":"2026-04-10T12:40:15","modified_gmt":"2026-04-10T11:40:15","slug":"platelet-rich-plasma-activation-are-there-differential-effects-in-reproductive-medicine","status":"publish","type":"post","link":"https:\/\/www.btitrainingcenter.com\/it\/platelet-rich-plasma-activation-are-there-differential-effects-in-reproductive-medicine\/","title":{"rendered":"Platelet-rich plasma activation: are there differential effects in reproductive medicine?"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row gap=&#8221;25&#8243; content_text_aligment=&#8221;left&#8221; row_background_lines=&#8221;no&#8221;][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3 class=\"title\">Abstract<\/h3>\n<div id=\"enc-abstract\" class=\"abstract-content selected\">\n<div id=\"enc-abstract\" class=\"abstract-content selected\">\n<p>The aim of this in vitro short report was to determine whether activation of platelet-rich plasma (PRP) results in differential effects on growth factor release and cell proliferation in reproductive medicine. This study involved PRP from five donors, activated with either CaCl2 (exogenous activation) or type I collagen (mimicking endogenous activation). The release of growth factors (EGF and PDGF-AB) and the proliferative response of human ovarian fibroblasts were analysed. PRP activated with CaCl2 formed stable clots and released statistically significant higher levels of EGF (871 \u00b1 426 pg\/mL) and PDGF-AB (26535 \u00b1 6477 pg\/mL) compared to collagen-activated PRP (EGF: 141 \u00b1 66 pg\/mL, PDGF-AB: 13060 \u00b1 2301 pg\/mL). Additionally, CaCl2-activated PRP induced greater proliferation in ovarian fibroblasts (34.90 \u00b1 17.82 ng\/mL DNA) than collagen-activated PRP (30.75 \u00b1 18.21 ng\/mL DNA). In conclusion, the activation of PRP with CaCl2 results in higher growth factor release and a stronger biological response compared to type I collagen-activation. These findings underscore the importance of standardized PRP activation protocols to enhance clinical outcomes in reproductive medicine.<\/p>\n<\/div>\n<p><strong class=\"sub-title\">Keywords:\u00a0<\/strong>Assisted reproductive techniques; Growth factors; PRGF; PRP; Platelet-rich plasma; Regenerative medicine.<\/p>\n<\/div>\n<p>[\/vc_column_text][vc_empty_space][vc_column_text]<\/p>\n<h3>Figures<\/h3>\n<p>[\/vc_column_text][vc_empty_space][\/vc_column][vc_column width=&#8221;1\/4&#8243; css=&#8221;.vc_custom_1775819242625{margin-top: 80px !important;margin-right: 5% !important;margin-left: 30px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;background-color: #F6F6F6 !important;border-radius: 25px !important;}&#8221;]<div class=\"qodef-animation-holder qodef-element-from-fade\" data-animation=\"qodef-element-from-fade\" data-animation-delay=\"300\"><div class=\"qodef-animation-inner\">[vc_column_text css=&#8221;&#8221;]<em>Accedi alla brochure di BTI:<\/em>[\/vc_column_text][vc_single_image image=&#8221;45541&#8243; img_size=&#8221;medium&#8221; alignment=&#8221;center&#8221; onclick=&#8221;custom_link&#8221; img_link_target=&#8221;_blank&#8221; css=&#8221;&#8221; link=&#8221;https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/6.-USA_PRP_ACTIVATION.pdf&#8221;]<a itemprop=\"url\" href=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/6.-USA_PRP_ACTIVATION.pdf\" target=\"_blank\" style=\"margin: 15px 5px 3px 33px\" class=\"qodef-btn qodef-btn-medium qodef-btn-solid btnWebRosa2 text12\"  >\n    <span class=\"qodef-btn-text\">Accedi al pdf<\/span>\n    <\/a><\/div><\/div>[\/vc_column][\/vc_row][vc_row content_placement=&#8221;middle&#8221; content_text_aligment=&#8221;center&#8221;][vc_column]<div class=\"qodef-image-gallery qodef-grid-list qodef-disable-bottom-space  qodef-ig-grid-type qodef-four-columns qodef-tiny-space  qodef-image-behavior-lightbox\">\n\t<div class=\"qodef-ig-inner qodef-outer-space\">\n\t\t\t\t\t<div class=\"qodef-ig-image qodef-item-space\">\n\t\t\t\t<div class=\"qodef-ig-image-inner\">\n\t\t\t\t\t\t\t\t\t\t\t<a itemprop=\"image\" class=\"qodef-ig-lightbox\" href=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/13048_2025_1667_Fig1_HTML.jpg\" data-rel=\"prettyPhoto[image_gallery_pretty_photo-337]\" title=\"&lt;strong&gt;Figure 1.&lt;\/strong&gt; Scheme of platelet-rich plasma (PRP) preparation and layout of experiments, including cell proliferation and ELISA assays\">\n\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/13048_2025_1667_Fig1_HTML-200x200.jpg\" alt=\"\" width=\"200\" height=\"200\" \/>\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<div class=\"qodef-ig-image qodef-item-space\">\n\t\t\t\t<div class=\"qodef-ig-image-inner\">\n\t\t\t\t\t\t\t\t\t\t\t<a itemprop=\"image\" class=\"qodef-ig-lightbox\" href=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/13048_2025_1667_Fig2_HTML.jpg\" data-rel=\"prettyPhoto[image_gallery_pretty_photo-337]\" title=\"&lt;strong&gt;Figure 2.&lt;\/strong&gt; EGF and PDGF-AB levels (pg\/mL) in the CaCl2 and collagen I activated samples and cell proliferation of human ovarian fibroblasts (measured as DNA in ng\/mL) after 72 h incubation with both preparations (* p\u2009&lt;\u20090.005)\">\n\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/13048_2025_1667_Fig2_HTML-200x200.jpg\" alt=\"\" width=\"200\" height=\"200\" \/>\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>[vc_empty_space height=&#8221;50px&#8221;][\/vc_column][\/vc_row][vc_row][vc_column]<a itemprop=\"url\" href=\"https:\/\/www.btitrainingcenter.com\/wp-content\/uploads\/2021\/08\/5-13048_2025_Article_1667.pdf\" target=\"_blank\"  class=\"qodef-btn qodef-btn-medium qodef-btn-solid btnWebRosa2\"  >\n    <span class=\"qodef-btn-text\">Scarica articolo<\/span>\n    <\/a>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p><strong>J Ovarian Res. 2025 Apr 24;18(1):84.<\/strong><br \/>\nThe aim of this in vitro short report was to determine whether activation of platelet-rich plasma (PRP) results in differential effects on growth factor release and cell proliferation in reproductive medicine. This study involved PRP from five donors, activated with either CaCl2 (exogenous activation) or type I collagen (mimicking endogenous activation). The release of growth factors (EGF and PDGF-AB) and the proliferative response of human ovarian fibroblasts were analysed. PRP activated with CaCl2 formed stable clots and released statistically significant higher levels of EGF (871 \u00b1 426 pg\/mL) and PDGF-AB (26535 \u00b1 6477 pg\/mL) compared to collagen-activated PRP (EGF: 141 \u00b1 66 pg\/mL, PDGF-AB: 13060 \u00b1 2301 pg\/mL). Additionally, CaCl2-activated PRP induced greater proliferation in ovarian fibroblasts (34.90 \u00b1 17.82 ng\/mL DNA) than collagen-activated PRP (30.75 \u00b1 18.21 ng\/mL DNA). <\/p>\n","protected":false},"author":2002,"featured_media":45541,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[157],"tags":[],"class_list":["post-47870","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicina-rigenerativa"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/posts\/47870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/users\/2002"}],"replies":[{"embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/comments?post=47870"}],"version-history":[{"count":3,"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/posts\/47870\/revisions"}],"predecessor-version":[{"id":47873,"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/posts\/47870\/revisions\/47873"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/media\/45541"}],"wp:attachment":[{"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/media?parent=47870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/categories?post=47870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/it\/wp-json\/wp\/v2\/tags?post=47870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}